Small Cell Lung Cancer Clinical Trials The clinical trials on this list are for small cell lung cancer All trials on the list are NCI-supported clinical trials, which are sponsored or otherwise financially supported by NCI NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out Clinical trials look at new ways to
Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research This randomized pilot clinical trial studies the side effects and best dose of naloxegol and to see how well it works in treating patients with stage IIIB-IV non-small cell lung cancer The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L
Lung Cancer Clinical Trials Research - Memorial Sloan Kettering . . . We are also conducting a number of clinical trials to test the effectiveness of genomics in treating non-small cell lung cancer If the molecular makeup of your tumor matches certain eligibility criteria, your doctor may offer you the opportunity to participate in the study Our experts can help determine which clinical trials are right for you
IMDELLTRA® SIGNIFICANTLY REDUCED RISK OF DEATH BY 40% IN SMALL CELL . . . "Small cell lung cancer is an extraordinarily aggressive and difficult-to-treat open-label clinical trial evaluating the efficacy and safety of IMDELLTRA as a treatment for patients living with SCLC who progressed on or after a single line of platinum-based chemotherapy 1 Five hundred and nine patients were randomized to receive either
Small cell lung cancer - Cancer Research UK Read more about A trial of chemoradiotherapy, pembrolizumab, and olaparib for small cell lung cancer (KEYLYNK-013) A trial of MK-7684A and chemotherapy for small cell lung cancer (KeyVibe-008) This trial is looking at a new drug called MK-7684A with chemotherapy to treat small cell lung cancer
Small Cell Lung Cancer (SCLC) | LUNGevity Foundation In addition to the approved treatments described above, researchers are testing several new types of treatment in clinical trials for people with small cell lung cancer, including targeted therapy and immunotherapy treatments among others 20 Clinical trials are considered a good option for small cell lung cancer patients, per NCCN guidelines
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on . . . Findings In this randomized clinical trial that included 585 patients with extensive-stage small cell lung cancer who had not previously received systemic therapy, serplulimab plus chemotherapy, compared with placebo plus chemotherapy, significantly improved overall survival (15 4 months vs 10 9 months, respectively; hazard ratio for death, 0 63)
Targeted treatments for small-cell lung cancer A rapid screening process identified a two-drug combination that shrank small-cell lung tumors, which are often fatal within weeks of recurrence In a pilot clinical trial, almost two-thirds of people who received the combination to treat recurrent small-cell lung cancer lived for at least six months